|
1.
|
|
|
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases
/
Zozaya, Néboa (Universidad de Las Palmas de Gran Canaria) ;
Arrizubieta Basterrechea, M.I. (Hospital Universitario de Galdakao-Usansolo) ;
Bollo, E. (Complejo Asistencial Universitario de León) ;
Castellvi, Ivan (Institut d'Investigació Biomèdica Sant Pau) ;
Espín, J. (Andalusian School of Public Health) ;
Ortego, N. (Hospital Universitario Clínico San Cecilio) ;
Poveda-Andrés, J.L. (Hospital Universitari i Politècnic La Fe (València)) ;
Rodríguez Portal, J.A. (Centro de Investigación Biomédica en Red - Enfermedades Respiratorias (CIBERES)) ;
Rivero, A. (Bioregión de Salud y Bienestar (BioMad)) ;
Marcos-Rodríguez, J.A. (Hospital Universitario Virgen Macarena) ;
Verde, L. (Integrated Health Area) ;
Universitat Autònoma de Barcelona
Objectives Our aim was to assess the value of nintedanib for non-idiopathic progressive fibrosing interstitial lung disease (non-IPF PF-ILD) and systemic sclerosis-associated ILD (SSc-ILD) in the Spanish context, using a multi-criteria decision analysis (MCDA). [...]
2022 -  10.1017/S0266462322000459
International Journal of Technology Assessment in Health Care, Vol. 38 Núm. 1 (january 2022) , p. e64
|
|
|
2.
|
|
9 p, 1.5 MB |
Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non-small cell lung cancer in Spain
/
Majem, Margarita (Institut d'Investigació Biomèdica Sant Pau) ;
Álvarez, Rosa (Hospital Gregorio Marañón (Madrid)) ;
Ortega, Ana Laura (Hospital Universitario de Jaén) ;
de Alda, Lucía Ruiz (Roche Farma) ;
Gordo, Rocío (Roche Farma) ;
García, J.Francisco (Roche Farma) ;
Ivanova-Markova, Yoana (Weber) ;
González-Domínguez, Almudena (Weber) ;
San Cristóbal, Raquel Sánchez (Weber) ;
Rojo, Federico (Hospital Universitario Fundación Jiménez Díaz) ;
Universitat Autònoma de Barcelona
In recent years, target therapies to specific molecular alterations in advanced non-small cell lung cancer (NSCLC) have been identified and have shown superior efficacy compared to non-targeted treatments. [...]
2022 - 10.33393/GRHTA.2022.2449
Global and Regional Health Technology Assessment, Vol. 9 (january 2022) , p. 82-90
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
14 p, 443.7 KB |
Exploring the Relationship Between Self-Compassion and Compassion for Others : The Role of Psychological Distress and Wellbeing
/
Garcia-Campayo, Javier (Fundación Instituto de Investigación Sanitaria Aragón) ;
Barceló-Soler, Alberto (Fundación Instituto de Investigación Sanitaria Aragón) ;
Martínez-Rubio, David (Universidad Europea de Valencia) ;
Navarrete Hidalgo, Jaime (Parc Sanitari Sant Joan de Déu) ;
Pérez-Aranda, Adrián (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica i de la Salut) ;
Feliu-Soler, Albert (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica i de la Salut) ;
Luciano, Juan V (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica i de la Salut) ;
Baer, Ruth (University of Oxford) ;
Kuyken, Willem (University of Oxford) ;
Montero-Marin, Jesus (Parc Sanitari Sant Joan de Déu)
We addressed construct validity and explored the relationship between self-compassion and compassion for others using the two main current operationalizations of compassion (Neff's and the Sussex-Oxford Compassion Scales, SOCSs). [...]
SAGE Publications Inc., 2023 - 10.1177/10731911231203966
Assessment
|
|
|
7.
|
|
9 p, 634.4 KB |
Cortical atrophy and amyloid and tau deposition in Down syndrome : A longitudinal study
/
Padilla, Concepción (Institut d'Investigació Biomèdica Sant Pau) ;
Montal, Victor (Institut d'Investigació Biomèdica Sant Pau) ;
Walpert, Madeleine J. (University of Cambridge. Cambridge Intellectual and Developmental Disabilities Research Group. Department of Psychiatry) ;
Hong, Young T. (University of Cambridge. Wolfson Brain Imaging Centre. Department of Clinical Neurosciences) ;
Fryer, Tim D. (University of Cambridge. Wolfson Brain Imaging Centre. Department of Clinical Neurosciences) ;
Coles, Jonathan (University of Cambridge. Division of Anaesthesia. Department of Medicine) ;
Aigbirhio, Franklin I. (University of Cambridge. Wolfson Brain Imaging Centre. Department of Clinical Neurosciences) ;
Hartley, Sigan L. (University of Wisconsin-Madison. Waisman Center) ;
Cohen, Ann (University of Pittsburgh. Department of Psychiatry) ;
Tudorascu, Dana L. (University of Pittsburgh. Department of Psychiatry) ;
Christian, Bradley T. (University of Wisconsin-Madison. Waisman Center) ;
Handen, Benjamin L. (University of Pittsburgh. Department of Psychiatry) ;
Klunk, William E. (University of Pittsburgh. Department of Psychiatry) ;
Holland, Anthony John (Cambridgeshire and Peterborough NHS Foundation Trust. Fulbourn Hospital) ;
Zaman, Shahid H. (Cambridgeshire and Peterborough NHS Foundation Trust. Fulbourn Hospital)
Introduction: The Down syndrome population has a high prevalence for dementia, often showing their first clinical symptoms in their 40s. Methods: In a longitudinal cohort, we investigate whether amyloid deposition at time point 1 (TP1) could predict cortical thickness change at time point 2 (TP2). [...]
2022 - 10.1002/dad2.12288
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring, Vol. 14 Núm. 1 (2022) , p. e12288
|
|
|
8.
|
|
10 p, 497.8 KB |
The AT(N) framework for Alzheimer's disease in adults with Down syndrome
/
Rafii, Michael S. (University of Southern California) ;
Ances, Beau M. (Washington University School of Medicine in St. Louis) ;
Schupf, Nicole (Columbia University Medical Center) ;
Krinsky-McHale, Sharon J. (NYS Institute for Basic Research in Developmental Disabilities) ;
Mapstone, Mark (University of California) ;
Silverman, Wayne (University of California) ;
Lott, Ira (University of California) ;
Klunk, Willian (University of Pittsburgh) ;
Head, Elizabeth (University of California) ;
Christian, Brad (University of Wisconsin Madison) ;
Lai, Florence (Massachusetts General Hospital) ;
Rosas, H.Diana (Harvard Medical School) ;
Zaman, Shahid (Cambridgeshire and Peterborough NHS Foundation Trust) ;
Petersen, Melissa E. (University of North Texas Health Science Center) ;
Strydom, Andre (King's College London) ;
Fortea, Juan (Institut d'Investigació Biomèdica Sant Pau) ;
Handen, Benjamin (University of Pittsburgh) ;
O'Bryant, Sid (University of North Texas Health Science Center) ;
Universitat Autònoma de Barcelona
The National Institute on Aging in conjunction with the Alzheimer's Association (NIA-AA) recently proposed a biological framework for defining the Alzheimer's disease (AD) continuum. This new framework is based upon the key AD biomarkers (amyloid, tau, neurodegeneration, AT[N]) instead of clinical symptoms and represents the latest understanding that the pathological processes underlying AD begin decades before the manifestation of symptoms. [...]
2020 - 10.1002/dad2.12062
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring, Vol. 12 Núm. 1 (2020) , p. e12062
|
|
|
9.
|
|
10 p, 1.7 MB |
Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests
/
Benejam, Bessy (Fundació Catalana Síndrome de Down) ;
Videla Toro, Laura (Institut d'Investigació Biomèdica Sant Pau) ;
Vilaplana, Eduard (Institut d'Investigació Biomèdica Sant Pau) ;
Barroeta, Isabel (Institut d'Investigació Biomèdica Sant Pau) ;
Carmona Iragui, María (Institut d'Investigació Biomèdica Sant Pau) ;
Altuna-Azkargorta, Miren (Institut d'Investigació Biomèdica Sant Pau) ;
Valldeneu, Silvia (Institut d'Investigació Biomèdica Sant Pau) ;
Fernandez, S. (Fundació Catalana Síndrome de Down) ;
Giménez, Sandra (Institut d'Investigació Biomèdica Sant Pau) ;
Iulita, Florencia (Institut d'Investigació Biomèdica Sant Pau) ;
Garzón, Diana (Institut d'Investigació Biomèdica Sant Pau) ;
Bejanin, Alexandre (Institut d'Investigació Biomèdica Sant Pau) ;
Bartrés-Faz, David (Universitat de Barcelona) ;
Videla, S. (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ;
Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ;
Blesa, Rafael (Institut d'Investigació Biomèdica Sant Pau) ;
Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
Fortea, Juan (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
We aimed to define prodromal Alzheimer's disease (AD) and AD dementia using normative neuropsychological data in a large population-based cohort of adults with Down syndrome (DS). Cross-sectional study. [...]
2020 - 10.1002/dad2.12047
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring, Vol. 12 Núm. 1 (2020) , p. e12047
|
|
|
10.
|
|
15 p, 1.5 MB |
Environmental assessment of a new building envelope material derived from urban agriculture wastes : the case of the tomato plants stems
/
Llorach-Massana, Pere (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ;
Cirrincione, Laura (Università degli Studi di Palermo. Department of Engineering) ;
Sierra-Perez, Jorge (Universidad de Zaragoza. Departamento de Ingeniería de Diseño y Fabricación) ;
Scaccianoce, Gianluca (Università degli Studi di Palermo. Department of Engineering) ;
La Gennusa, Maria (Università degli Studi di Palermo. Department of Engineering) ;
Peña, Javier (Escola Universitària de Disseny i Enginyeria de Barcelona) ;
Rieradevall, Joan (Universitat Autònoma de Barcelona. Departament d'Enginyeria Química, Biològica i Ambiental)
Purpose: Decarbonizing cities is one of today's biggest challenges. In this regard, particular attention has been paid on improving the environmental performance of buildings. In this framework, this work consists in assessing the environmental impact of an innovative building envelope component derived from urban agriculture (UA) wastes. [...]
2023 - 10.1007/s11367-023-02152-2
The international journal of life cycle assessment, (March 2023)
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
